Kodiak Sciences Inc is is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. Kodiak Sciences Inc is is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases.
Kodiak Sciences to Host Investor R&D Day on September 23, 2024 in New York City PR Newswire PALO ALTO, Calif., Sept. 17, 2024 PALO ALTO, Calif., Sept. 17, 2024 /PRNewswire/ -- Kodiak Sciences...
Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results PR Newswire PALO ALTO, Calif., Aug. 14, 2024 PALO ALTO, Calif., Aug. 14, 2024 /PRNewswire/ -- Kodiak...
Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences PR Newswire PALO ALTO, Calif., May 29, 2024 PALO ALTO, Calif., May 29, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.08 | -2.94117647059 | 2.72 | 2.835 | 2.48 | 173171 | 2.64856694 | CS |
4 | -0.25 | -8.65051903114 | 2.89 | 2.96 | 2.29 | 156230 | 2.56654267 | CS |
12 | 0.25 | 10.460251046 | 2.39 | 3.33 | 2.185 | 214757 | 2.71723333 | CS |
26 | -3.592 | -57.6379974326 | 6.232 | 7.77 | 2.185 | 398353 | 3.89476006 | CS |
52 | 0.69 | 35.3846153846 | 1.95 | 7.77 | 1.37 | 623292 | 3.54432948 | CS |
156 | -100.42 | -97.4383854066 | 103.06 | 131.97 | 1.37 | 700886 | 10.76471183 | CS |
260 | -14.01 | -84.1441441441 | 16.65 | 171.21 | 1.37 | 567036 | 28.26222921 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.